첨단 치료 의약품 시장 규모, 점유율, 성장 분석 : 제품 유형별, 치료법별, 용도별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Advanced Therapy Medicinal Products Market size was valued at USD 27.04 Billion in 2024 and is poised to grow from USD 31.5 Billion in 2025 to USD 106.89 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026-2033).

The global market for advanced therapy medicinal products (ATMPs) is primarily influenced by the prevalence of rare and genetic disorders, the escalating need for curative therapies, and significant advancements in cell and gene therapy technologies. Investments in regenerative medicine are increasing, complemented by supportive regulatory frameworks for innovative treatments. As a result, there is a growing confidence in the sector, prompting heightened investments from pharmaceutical, biotech firms, and academic institutions. Innovations in manufacturing and development processes are crucial for scalability, leading companies to adopt automated methods and contract collaborations to optimize production and cost efficiency. However, challenges such as high treatment costs, complex manufacturing needs, regulatory hurdles, and supply chain constraints may inhibit market penetration and growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Advanced Therapy Medicinal Products market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Advanced Therapy Medicinal Products Market Segments Analysis

Global advanced therapy medicinal products market is segmented by product type, therapy type, application, delivery mode, end user, and region. Based on product type, the market is segmented into gene therapy medicinal products, somatic cell therapy medicinal products, tissue engineered products, and combined ATMPs. Based on therapy type, the market is segmented into autologous therapies and allogeneic therapies. Based on application, the market is segmented into oncology, cardiovascular disorders, neurological disorders, musculoskeletal disorders, rare genetic disorders, dermatology, ophthalmology, and others. Based on delivery mode, the market is segmented into ex vivo therapy and in vivo therapy. Based on end user, the market is segmented into hospitals, specialty clinics, research institutes, and academic institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Advanced Therapy Medicinal Products Market

Advancements in cell and gene discovery, alongside technological innovations, have significantly enhanced our understanding of diseases and broadened the array of potential therapies, leading to a surge in clinical programs and commercial opportunities. Improved delivery platforms and technologies allow for the targeting of more complex diseases effectively. Collaborations between industry and academia are accelerating the translation of research into practical applications. This concentrated research effort is poised to enhance the ecosystem of specialized manufacturing and regulatory processes, fostering greater investment, expanding capacity, and ultimately driving growth in the Global Advanced Therapy Medicinal Products market.

Restraints in the Global Advanced Therapy Medicinal Products Market

The Global Advanced Therapy Medicinal Products market faces significant restraints due to complex and inconsistent approval processes that increase uncertainty and prolong the timeline for introducing innovative therapies. Varying international standards regarding clinical data, manufacturing oversight, and product quality require meticulous planning and a deep understanding of global regulatory frameworks, resulting in a more resource-demanding process for launching new therapeutics. Additionally, evolving regulatory expectations and safety standards can hinder research initiatives and investments, ultimately limiting the immediate adoption of groundbreaking products. This combination of factors contributes to a challenging environment for market participants aiming to introduce advanced therapies.

Market Trends of the Global Advanced Therapy Medicinal Products Market

The Global Advanced Therapy Medicinal Products market is witnessing a significant shift towards personalized cell therapies, emphasizing treatments tailored to the unique genetic and immune profiles of individual patients. This trend is fostering collaborations among clinicians, biotech firms, and specialized contract manufacturers, driving the development of flexible treatment protocols and comprehensive care pathways. Concurrently, the demand for modular manufacturing sites and decentralized clinical delivery centers is increasing, prompting payers and healthcare systems to explore outcomes-based reimbursement models. Moreover, patient-centered logistics and the integration of real-world data are shaping commercialization strategies, further steering the market away from traditional one-size-fits-all therapies towards innovative precision models catering to diverse medical conditions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Advanced Therapy Medicinal Products Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Gene Therapy Medicinal Products
• Somatic Cell Therapy Medicinal Products
• Tissue Engineered Products
• Combined ATMPs

Global Advanced Therapy Medicinal Products Market Size by Therapy Type & CAGR (2026-2033)

• Market Overview
• Autologous Therapies
• Allogeneic Therapies

Global Advanced Therapy Medicinal Products Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Cardiovascular Disorders
• Neurological Disorders
• Musculoskeletal Disorders
• Rare Genetic Disorders
• Dermatology
• Ophthalmology
• Others

Global Advanced Therapy Medicinal Products Market Size by Delivery Mode & CAGR (2026-2033)

• Market Overview
• Ex Vivo Therapy
• In Vivo Therapy

Global Advanced Therapy Medicinal Products Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Research Institutes
• Academic Institutes

Global Advanced Therapy Medicinal Products Market Size & CAGR (2026-2033)

• North America (Product Type, Therapy Type, Application, Delivery Mode, End User)
  • US
  • Canada
• Europe (Product Type, Therapy Type, Application, Delivery Mode, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Therapy Type, Application, Delivery Mode, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Therapy Type, Application, Delivery Mode, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Therapy Type, Application, Delivery Mode, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bluebird bio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mesoblast Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMarin Pharmaceutical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• uniQure N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orchard Therapeutics plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adaptimmune Therapeutics plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Legend Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autolus Therapeutics plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sarepta Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vericel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stempeutics Research Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations